- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
International Journal of Cell Biology
Volume 2012 (2012), Article ID 849541, 15 pages
Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process
1Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
2Department of Neurology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland
3Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland
4Department of Ophthalmology, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland
Received 19 April 2012; Accepted 21 June 2012
Academic Editor: Anton M. Jetten
Copyright © 2012 Antero Salminen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The NF-κB signaling system and the autophagic degradation pathway are crucial cellular survival mechanisms, both being well conserved during evolution. Emerging studies have indicated that the IKK/NF-κB signaling axis regulates autophagy in a context-dependent manner. IKK complex and NF-κB can enhance the expression of Beclin 1 and other autophagy-related proteins and stimulate autophagy whereas as a feedback response, autophagy can degrade IKK components. Moreover, NF-κB signaling activates the expression of autophagy inhibitors (e.g., A20 and Bcl-2/xL) and represses the activators of autophagy (BNIP3, JNK1, and ROS). Several studies have indicated that NF-κB signaling is enhanced both during aging and cellular senescence, inducing a proinflammatory phenotype. The aging process is also associated with a decline in autophagic degradation. It seems that the activity of Beclin 1 initiation complex could be impaired with aging, since the expression of Beclin 1 decreases as does the activity of type III PI3K. On the other hand, the expression of inhibitory Bcl-2/xL proteins increases with aging. We will review the recent literature on the control mechanisms of autophagy through IKK/NF-κB signaling and emphasize that NF-κB signaling could be a potent repressor of autophagy with ageing.
One part of the aging process involves a decline in cellular housekeeping functions disturbing the maintenance of organism homeostasis [1, 2]. The accumulation of damaged and defective components increases cellular stress, for example, oxidative stress, which activates cellular defence mechanisms including NF-κB signaling pathway and innate immunity system, such as inflammasomes [3–5] (Section 3.1). Aging is associated with a low-grade proinflammatory phenotype which further interferes with housekeeping and cellular homeostasis. Recent studies have indicated that autophagy is a crucial cleansing system preventing inflammation but its capacity clearly declines with aging [6–8]. The NF-κB signaling system and the autophagic degradation pathway have been closely conserved during evolution and emerging studies indicate that these systems have many context-dependent interactions with each other. We will review the recent literature on the control mechanisms of autophagy by NF-κB signaling and particularly we will focus on its context-dependent regulation during the aging process.
By definition, autophagy or autophagocytosis is a cellular self-digestion process involving the uptake of cellular components and organelles for degradation by lysosomal system. The hallmark of autophagy is the appearance of autophagosomes which subsequently fuse with primary lysosomes to form autolysosomes where the ingested material is digested by lysosomal enzymes. This process is called macroautophagy, hereafter entitled autophagy. There also exist microautophagy and chaperone-mediated autophagy which deliver cytoplasmic material directly into the lysosomes without the formation of autophagosome. Several reviews have detailed the mechanisms involved in autophagosome formation, for example, over thirty autophagy-related (ATG) proteins are known to participate in this process [9–11].
Beclin 1 and its interactome, that is, proteins interacting with Beclin 1, have a crucial role in the vesicle nucleation during autophagosome formation [12, 13]. Beclin 1 and hVPS34, a class III phosphatidylinositol-3 kinase, assemble the core complex which then cooperates with several stable and transient binding partners in order to establish phagophore formation . Autophagosomes most likely originate in the specialized subdomains of endoplasmic reticulum but in addition, Golgi complex and endosomes seem to supply some lipids and proteins to elongating autophagosome membranes . Atg14L protein targets Beclin 1/hVps34 complex to the cup-shaped protrusion of the endoplasmic reticulum, called omegasome . Beclin 1 is a BH3-only protein which can interact with the antiapoptotic Bcl-2 and Bcl-xL proteins which inhibit the autophagosome formation in the initiation phase . However, Bcl-2/xL proteins can be phosphorylated by JNK1, induced by, for example, starvation and ceramides, which block its inhibitory binding to Beclin 1 [13, 16]. Moreover, competitive binding of Bcl-2/xL to other BH3-only proteins, such as BNIP3 and BAD, also prevents Beclin 1 inhibition and induces autophagy [13, 17]. Interactions between Beclin 1 and antiapoptotic Bcl-2/xL proteins are known to regulate the crosstalk between autophagy and apoptosis . Another important regulatory complex in addition to Beclin 1 is the ULK1/2 complex which is controlled by mTOR kinase [10, 19]. mTOR is a potent inhibitor of the ULK1 complex and thus also represses autophagy. There are several extensive reviews on the regulation of autophagy and its physiological and pathological functions [19–22].
1.2. IKK-NF-κB Signaling
NF-κB signaling pathway is involved in the regulation of multiple cellular functions, for example, apoptosis, autophagy, cellular proliferation, differentiation, metabolism, and adaptive and innate immunity responses. The proteins of three families lie in the center of inducible NF-κB signaling module, (i) the IKK kinase complex including IKKα, IKKβ, and IKKγ (also called NEMO) are upstream activators of NF-κB signaling, (ii) the NF-κB/Rel DNA-binding complexes involving the NF-κB proteins p50 and p52 and the Rel family members (RelA/p65, RelB, and c-Rel), and (iii) several typical and atypical inhibitory IκB proteins (IκBα, IκBβ, IκBε, IκBζ, IκBη, IκBNS, Bcl-3, p100, and p105) [23–25]. Briefly, the homo- and heterodimers of NF-κB/Rel components assemble inactive complexes with IκB proteins in the cytoplasm. After stimulation by upstream kinases, IKKα/β kinases phosphorylate IκB proteins which are subsequently ubiquitinated and degraded in proteasomes. Afterwards, dissociated NF-κB/Rel dimers translocate to nuclei where they transactivate the expression of hundreds of genes. This is the basic principle of NF-κB function but the NF-κB pathway can be controlled at several levels which means that NF-κB signaling is a highly context-dependent process.
Recently, Tieri et al.  applied a network analysis to reveal the interactome map of NF-κB signaling pathway. They observed that the integrated network affecting NF-κB activation consisted of 622 proteins whereas the NF-κB signaling was able to regulate the expression of 426 proteins of which 49 proteins established a feedback loop controlling NF-κB activity. Many of the upstream signaling pathways converging in the regulation of IKK complex and directly NF-κB components have been characterized [27–29]. The upstream pathways were earlier classified into canonical and noncanonical pathways but currently, it seems that this scenario is not adequate due to intense crosstalk between different signaling pathways. Moreover, IKK complex has many NF-κB-independent, context-dependent functions, for example, in immunity and cancer . Posttranslational modifications of NF-κB components are a potent way to control their transactivation efficiency . Thus, modifications such as phosphorylation, acetylation, methylation, sulfhydration, sumoylation, and ubiquitination can regulate the duration and capacity of transactivation and possibly also the dimerization of NF-κB/Rel components and their recruitment of proper coregulators to specific DNA sites [31–33]. Context-dependent factors affect the specificity which links different stimuli to the activation of relevant NF-κB-driven target genes. For instance, NF-κB signaling generates different responses in acute and chronic inflammation . It is most likely that context-dependent factors control the responses of NF-κB signaling with respect to apoptosis, autophagy, and activation of inflammation.
2. IKK-NF-κB Axis Is a Context-Dependent Regulator of Autophagy
There is a substantial literature indicating that NF-κB signaling and autophagy are reciprocally involved in the control of cellular survival and any dysfunction in this crosstalk can evoke detrimental effects. For instance, it is known that a decline in autophagy can stimulate NF-κB-dependent inflammatory responses  whereas an increase in autophagy can prevent inflammatory responses . On the other hand, the inhibitors of NF-κB signaling are effective activators of autophagocytosis, for example, AMPK  and SIRT1 signaling [38, 39]. However, there is mounting evidence that NF-κB signaling can either activate or inhibit autophagocytosis in a context-dependent manner (see below). Moreover, several proteins, for example, Bcl-2 family members are key players both in the regulation of autophagy and apoptosis indicating that there could be a context-dependent crosstalk via the activation of IKK-NF-κB signaling axis. Recently, Trocoli and Djavaheri-Mergny  reviewed the complex interplay between NF-κB signaling and autophagy in cancer formation.
2.1. IKK Complex Controls Autophagy and Vice Versa via Feedback Response
Criollo et al.  were the first investigators who demonstrated that several autophagic inducers stimulated autophagy via the activation of the IKK complex but without any involvement of NF-κB signaling in several cell lines. They also observed that starvation and rapamycin did not induce autophagy in the livers of mice carrying a conditional knockout of IKKβ. They did not reveal any exact mechanism but they noted that the IKK complex promoted autophagy by (i) activating AMPK, (ii) inhibiting mTOR, and (iii) depleting nuclear p53, all of which are crucial inducers of autophagy. On the other hand, Comb et al.  demonstrated that cellular starvation induced the expression of Atg5, BECN1, and LC3, important autophagy genes, in the IKKα and IKKβ-dependent manner but independently of NF-κB signaling. Interestingly, starvation stimulated the expression of NF-κB-dependent antiapoptotic genes, for example, Bnip3 and cIAP2. These studies indicate that in some circumstances, IκB kinases can stimulate canonical autophagy and induce the expression of autophagy-related genes without NF-κB transcription factors (Figure 1). Recently, Comb et al.  revealed that the regulatory subunit of PI3K, p85α, is an IKK phosphorylation target in cellular starvation inducing the transient feedback inhibition of PI3K/Akt signaling and subsequently triggering autophagy via the inhibition of mTOR activity. It is important to emphasize here that the autophagy activated by the IKK complex in acute stress, extending up to some hours, was transient, probably due to the effective feedback inhibition.
Hsp90 chaperone is a major stability factor for the activation of IKK signalosome [44–46]. It is known that acute cellular stress can trigger the dissociation of Hsp90 from the IKK complex which inhibits NF-κB signaling [46, 47]. Interestingly, Qing et al.  demonstrated that the treatment of cells with geldanamycin, an inhibitor of Hsp90, induced the degradation of IKKα and IKKβ proteins via autophagy and neither ubiquitination nor proteasomes were involved in the degradation of the IKK complex. Moreover, they also revealed that geldanamycin stimulated the autophagic degradation of NIK, a key kinase activating IKKα in the noncanonical NF-κB pathway . These studies indicate that Hsp90 has a crucial role in the control of signaling via the IKK-NF-κB axis, that is, acute insults trigger IKK-mediated autophagy and block NF-κB-driven transcription whereas prolonging the stress will stimulate the autophagic degradation of the IKK complex, thus, preventing apoptotic cell death. Niida et al.  observed that the excessive activation of IKKβ could trigger its monoubiquitination by Ro52, an E3 ubiquitin ligase, which subsequently enhanced the autophagic degradation of IKKβ (Figure 1). Moreover, Keap1, another E3 ligase, can interact with IKKβ, but not with IKKα, and thus induce the autophagic degradation of IKKβ which consequently inhibits NF-κB signaling . In conclusion, it seems that the IKK complex and autophagy have a mutual function in acute cellular stress, that is, at its onset, IKK-induced autophagy ensures the energy supply and supports housekeeping but later, autophagic degradation of the IKK complex prevents the excessive activation of IKKs and their harmful responses, such as tumorigenesis and inflammation (Figure 1).
2.2. NF-κB Activation Stimulates Autophagy
There is an interesting context-dependent activation of autophagy between the IKK complex and its downstream target, the NF-κB system. Occasionally, the IKK complex can trigger autophagy without involvement of NF-κB system (Section 2.1.) whereas under other circumstances, NF-κB is a crucial inducer of autophagy. For instance, Nivon et al.  demonstrated that NF-κB signaling triggered autophagy during the heat shock recovery period and thus supported cellular survival. Inhibition of NF-κB activation blocked the autophagic response and augmented cell death after a heat shock stress. Recently, they revealed that the NF-κB signaling induced by heat stress increased the expression level of BAG3-HspB8 complexes which enhanced the autophagic uptake and elevated the clearance of irreversibly damaged proteins . It is known that the BAG3-HspB8 chaperone complex targets misfolded proteins for macroautophagy . This implies that NF-κB signaling has an important role in the maintenance of protein quality during heat shock. Excessive heat shock can also induce an atypical activation of NF-κB signaling through a thermolabile dissociation of the NF-κB complex without any phosphorylation of IκB proteins and thus no involvement of the IKK signalosome is necessary .
Copetti et al.  demonstrated that the p65/RelA component can induce the transcription of the BECN1 gene (Beclin 1) and thus stimulate autophagy in T-cells. They identified some conserved NF-κB binding sites both in the promoter and the first intron of the BECN1 gene in mice and humans. Copetti et al.  observed that p65 regulated Beclin 1 expression in several cell types and consistently enhanced the induction of autophagy. Their study indicated that the BECN1 gene is one of the target genes of NF-κB signaling. Bhatnagar et al.  revealed that the proinflammatory cytokine TWEAK, a well-known NF-κB-dependent inducer of atrophy in skeletal muscles , could stimulate the expression of several autophagy genes, for example, BECN1, LC3B, Atg5, in C2C12 myotubes and it also activated autophagocytosis. They also confirmed that the TWEAK-provoked response was mediated by NF-κB signaling. It is known that TWEAK can stimulate NF-κB signaling via TRAF6 and induce a prolonged activation of NF-κB . TRAF6, an E3 ubiquitin ligase, can also ubiquitinate Beclin 1 in BH3 domain and trigger autophagy . It seems that NF-κB signaling can directly stimulate the expression of autophagy-related genes in order to support cell survival but also organismal life since skeletal muscle atrophy supplies amino acids, for example, in starvation (Figure 1).
Jiang et al.  revealed that the downregulation of Hsp90 expression by selenite inhibited the signaling of the IKK/NF-κB pathway and significantly reduced the expression of Beclin 1 which subsequently increased the transition from autophagy to apoptosis. Recently, Romano et al.  observed that ionizing radiation stimulated NF-κB signaling via the activation of FKBP51 in malignant melanoma cells. Subsequently, the activation of NF-κB protected from apoptotic cell death by inducing XIAP expression and promoting BAX degradation by autophagy. The inhibition of FKBP51 clearly promoted apoptosis in irradiated melanoma cells. These studies indicate that NF-κB-dependent autophagy can prevent apoptotic cell death. However, there are several reports which have demonstrated that the NF-κB-dependent activation of autophagy could lead to autophagic cell death [63–65]. Currently, it is a matter of debate whether autophagy can be the mechanism of cell death .
2.3. NF-κB Signaling Indirectly Suppresses Autophagy
There are many observations which indicate that under certain circumstances the NF-κB system can also mediate the suppression of autophagy. For instance, Djavaheri-Mergny et al.  observed that NF-κB signaling inhibited the autophagy induced by TNF-α in different cell types. They revealed that NF-κB signaling activated mTOR kinase which is the major inhibitor of autophagy. Moreover, suppression of NF-κB signaling in this model stimulated the expression of Beclin 1 and subsequently triggered autophagy in TNF-α-treated cells. This response was mediated by ROS which can context-dependently promote autophagocytosis . Upon TNF-α treatment, the activation of IKKα/β can repress TSC complex [69, 70], a potent inhibitor of mTOR, and thus induce the activation of autophagy. On the other hand, NF-κB signaling, induced by TNF-α, can inhibit the expression of PTEN, a dual-specificity phosphatase that inhibits insulin/Akt pathway [71, 72]. The insulin/Akt pathway is a potent activator of mTOR and thus NF-κB signaling can inhibit autophagy by stimulating this homeostatic pathway (Figure 1). Interestingly, signaling via insulin/IGF pathway can accelerate the aging process . Schlottmann et al.  demonstrated that the prolonged activation of NF-κB signaling inhibited the expression of BECN1 and Atg5 genes and repressed autophagy in macrophages. Interestingly, it seems that the activation of NF-κB signaling in acute stress can provoke autophagy (Section 2.2) whereas a delayed activation can suppress autophagy. Probably, this is a feedback regulation which could prevent cells from autophagic cell death. It is known that NF-κB signaling can control the expression of several, well-known activators and inhibitors of autophagy and in that way indirectly and context-dependently regulate autophagy (Figure 1).
2.3.1. NF-κB Signaling Enhances the Expression of Autophagy Inhibitors
Beclin 1 network is a crucial regulator of autophagocytosis but also apoptosis [13, 18, 75]. Beclin 1 protein contains three conserved domains, that is, BH3 (Bcl-2-homology-3), ECD (evolutionarily conserved domain) and CCD (coiled-coil domain) through which it binds a number of proteins to create a functional network called the Beclin 1 interactome. For instance, Beclin 1 binds with Bcl-2 and Bcl-xL, which are the major antiapoptotic proteins and thus the Beclin 1 interactome can control both autophagy and apoptosis (Figure 2). Binding of Bcl-2 and Bcl-xL to Beclin 1 protein inhibits the formation of the initiation complex and subsequently blocks autophagocytosis. However, the phosphorylation of Bcl-2 by JNK1  and Beclin 1 by DAPK  can dissociate the interaction between Beclin 1 and Bcl-2/xL which supports autophagocytosis. The versatile balance between the proteins binding to Bcl-2/xL and Beclin 1 controls the activity of autophagy . For instance, the overexpression of Bcl-xL delays the onset of autophagy  whereas downregulation of Bcl-2 stimulates autophagy . Interestingly, it is known well that NF-κB signaling is a potent inducer of Bcl-2 and Bcl-xL transcription [79–83] and thus the expression of Bcl-2/xL inhibits apoptosis but simultaneously it also represses autophagy. Moreover, NF-κB signaling stimulates the transcription of Bfl-1/A1, a Bcl-2 family member and a Beclin 1 binding partner, which also negatively regulates autophagy [84, 85].
Recently, Chang et al.  characterized the Bcl-2-interacting protein NAF-1 (nutrient-deprivation autophagy factor-1) in endoplasmic reticulum, which is required for the interaction between Beclin 1 and Bcl-2. It is known that Bcl-2 inhibits the Beclin 1-mediated autophagy only if it is present in ER. Chang et al.  demonstrated that NAF-1 also interacted with IP3 receptor and mediated the Bcl-2-induced regulation of ER calcium homeostasis. BH3 protein BIK displaced NAF-1 from Bcl-2 and triggered autophagy. There are also reports indicating that the overexpression of Bcl-2 could activate NF-κB signaling via the MEKK-1/IKKβ pathway [87, 88]. This might indicate a positive feedback in the prevention of apoptosis. In conclusion, there is mounting evidence indicating that NF-κB signaling can induce autophagy by inducing the transcription of autophagy genes (Section 2.2) but on the other hand, it can repress autophagy by stimulating the expression of antiapoptotic, Bcl-2 family genes. It seems that NF-κB signaling controls the crosstalk between autophagy and apoptosis in a context-dependent manner.
The ubiquitination of Beclin 1 is a potent enhancer of autophagy . Shi and Kehrl  demonstrated that LPS as well as many other stimuli of autophagy in murine macrophages, for example, IL-1, IFNγ, and amino acid starvation, induced Lys-117 ubiquitination of Beclin 1. They observed that TRAF6 was able to bind to Beclin 1 and it triggered a K63-linked ubiquitination at the BH3 site of Beclin 1 protein. They also revealed that ubiquitination facilitated the oligomerization of Beclin 1 and thus enhanced autophagy, probably preventing the formation of inhibitory complexes between Bcl-2/xL and Beclin 1. Shi and Kehrl  also observed that A20, a ubiquitin-editing enzyme , provoked the deubiquitination of Beclin 1 and in that way inhibited autophagic capacity of Beclin 1. Interestingly, A20 deubiquitinase is a target gene of NF-κB transactivation  but on the other hand, the expression of A20 establishes a negative feedback mechanism to shut down the activation of NF-κB system [91, 92]. The activation of the NF-κB signaling pathway, for example, by TNF and IL-1 receptors, involves several regulatory steps mediated by K63 ubiquitination at the level of upstream kinases and inhibitory IκB proteins [89, 91]. For instance, A20 inhibits the activity of IKK complex . A20 is a well-known inhibitor of NF-κB-mediated inflammatory responses occurring in Crohn's disease, rheumatoid arthritis, and psoriasis . It seems that A20 and its coactivator ABIN-1  could be potent inhibitors of Beclin 1 function enhancing its deubiquitination and thus supporting its complex formation with Bcl-2/xL proteins during the chronic inflammation.
Recently, Jounai et al.  observed that Beclin 1 can interact with the members of NLR family of inflammasome receptors, for example, NLRC4, NLRP3, NLRP4, and NLRP10. They revealed that the evolutionarily conserved domain (ECD) of Beclin 1 could physically bind to the NACHT domain of NLR proteins. In particular, the NACHT of NLRP4 induced a tight binding with Beclin 1. Jounai et al.  also revealed that NLRP4 and NLRC4 inhibited the autophagosome formation whereas NLRP4 could also repress the maturation of autophagosomes to autolysosomes. NLR proteins are important intracellular danger sensors assembling inflammasomes which in turn activate inflammatory caspases to cleave the proforms of IL-1β and IL-18 into the mature, secreted cytokines [4, 96]. Bauernfeind et al.  demonstrated that the activation of inflammasomes was dependent on the priming phase in which NF-κB signaling induced the expression of NLRP3 and the proforms of IL-1β and IL-18 in order to assemble inflammasomes. Currently, it is not known whether other NLR receptors require the priming stage to facilitate inflammasome activation. However, it seems that inflammasome receptors can bind to Beclin 1 and thus repress autophagy. On the other hand, Shi et al.  demonstrated that the activation of autophagy by inflammatory signals induced the ubiquitination of ASC adapter of inflammasomes and subsequently triggered their degradation via p62-mediated selective autophagy. This indicates that autophagy can repress the overwhelming inflammation and imply that a decline in autophagic capacity can generate chronic inflammatory conditions both during aging process and age-related diseases (Section 3). There are also reports that antiapoptotic proteins Bcl-2/xL could bind to NLRP1 protein and thus inhibit its inflammasome function [99, 100]. These observations imply that antiapoptotic proteins Bcl-2/xL can also regulate inflammation, in addition to autophagocytosis.
There is a substantial literature indicating that ROS and oxidative stress can control autophagocytosis [68, 101, 102]. Moreover, inducible nitric oxide synthase (iNOS), induced by NF-κB activation, stimulates the production of nitric oxide (NO) which has a crucial role as a messenger molecule but its dysfunction generates nitrosative stress and provokes many diseases . Recently, Sarkar et al.  demonstrated that NO could inhibit autophagy by S-nitrosylating and thus inhibiting the activities of IKKβ and JNK1, potent inducers of autophagy. The inhibition of JNK1 by NO reduces the phosphorylation of Bcl-2 and in that way increases the formation of inhibitory Bcl-2/Beclin 1 complexes. The S-nitrosylation of IKKβ reduces its capacity to activate AMPKα, an important inducer of autophagy by activating ULK1 and repressing mTOR . These studies indicate that cellular stress can repress autophagy via the reactive nitrogen species induced by NF-κB signaling.
2.3.2. NF-κB Signaling Represses the Expression of Autophagy Activators
The interactome of Beclin 1 contains several binding factors, for example, Bcl-2 and Bcl-xL (Section 2.3.1), but the Beclin 1 complexes can be disrupted by BH3 domain containing proteins, for example, BNIP3 and NIX/BNIP3L, which bind to Bcl-2 and Bcl-xL proteins and subsequently activate the formation of the Beclin 1/hVps34/hVps15 interaction, an initiation complex in the process of autophagocytosis . Hypoxia is a potent inducer of BNIP3 and NIX expression which in particular, enhances the autophagic uptake of mitochondria, a process called mitophagy . It is known that BNIP3 and NIX represent a survival mechanism in moderate stress but excessive insults contribute to mitochondrial damage and consequently to cell death through the induction of apoptosis, for example, in the hypoxic myocardium [106, 107]. Several transcription factors regulate the transcription of Bnip3 gene, for example, HIF-1α, NF-κB, E2F1, FoxO3, p53, and Sp1 [107–109]. Moreover, the promoter of Bnip3 contains several GC-rich regions and is hypermethylated and silenced in many cancers. Kirshenbaum and coworkers demonstrated that the binding of p65 component of the NF-κB complex induced the transcriptional repression of BNIP3 expression in rat ventricular myocytes [109–111] (Figure 2). Under physiological conditions, the NF-κB complex interacts with HDAC1, histone deacetylase 1, and prevents the binding of E2F1 to the adjacent sites in Bnip3 promoter. In hypoxic conditions or during the deficiency of NF-κB, binding of E2F1, HIF-1α, and FoxO3 factors stimulate autophagy which can lead to cell death. Moreover, p53 can also suppress the expression of BNIP3 by binding to the Bnip3 promoter and recruiting the corepressor Sin3a . These studies indicated that the expression level of BNIP3 is a crucial regulator of autophagy through Beclin 1 interactome. They also revealed that autophagy is under the epigenetic regulation via BNIP3 expression.
Starvation is the most crucial, evolutionarily conserved inducer of autophagy . Wei et al.  demonstrated that starvation triggered the phosphorylation of Bcl-2 at several residues and induced its dissociation from Beclin 1 which provoked autophagocytosis. They observed that phosphorylation was caused by the stress-activated JNK1. Many other stress-related factors can also activate autophagy through the JNK1 pathway, stimulating the dissociation of Bcl-2/Beclin 1 complex, for example, ceramides . There is substantial evidence that NF-κB signaling suppresses the JNK1 signaling cascade and thus can protect cells from JNK1-induced apoptosis [114–117]. Several studies have indicated that NF-κB signaling can induce the expression of antioxidants and antiapoptotic proteins which prevent the prolonged activation of JNK1 signaling for example, during the TNF-α exposure. For instance, NF-κB signaling stimulates the expression of Gadd45β which inhibits the activity of MKK7, an upstream kinase of JNK1 . Moreover, A20 and XIAP, which are also induced by NF-κB, inhibit the TNF-α-mediated JNK1 activation [115, 116].
It is well known that ROS and redox signaling can increase autophagocytosis via many different mechanisms, in addition to JNK1 regulation [68, 101, 102]. For instance, ROS can oxidize cysteine-rich domains of ATG4 and Rubicon and thus enhance autophagy [68, 102]. Currently, the exact mechanisms still await to be characterized. Recently, Lipinski et al.  demonstrated that ROS can activate type III PI3 kinase, also known as hVSP34 which is a Beclin 1-interacting protein and the major enhancer of autophagy . Regulation of antioxidant gene expression is one of the major functions of NF-κB signaling  and thus NF-κB activity can repress autophagy by reducing the presence of ROS although in many contexts it can protect cells from injuries induced by excessive ROS production.
There are several aspects indicating that autophagy is a tumor suppressor mechanism, for example, Beclin 1 is a haploinsufficient tumor suppressor protein, and chronic inhibition of autophagy can increase carcinogenesis [120, 121]. Moreover, p53 can have both activating and inhibiting effects on autophagy, that is, nuclear p53 stimulates autophagy but in cytoplasm, p53 represses autophagy [120, 122]. On the other hand, there is mounting evidence pointing out that NF-κB signaling can induce tumorigenesis, either directly or via inflammation . Whether or not this is linked to the capacity of NF-κB to repress autophagy still remains to be revealed. Interestingly, several studies have indicated that p53 and NF-κB have many antagonistic functions . Nuclear p53 is a potent inducer of autophagy since it can transactivate many activators of autophagy, for example, DRAM1, DAPK-1 and SESN2 . However, the exact mechanism by how NF-κB-dependent signaling could inhibit the transcriptional activity of p53 is not known.
In conclusion, there is substantial literature which shows that NF-κB signaling can either stimulate or inhibit autophagocytosis. It is clear that the control of autophagy by NF-κB system is a context-dependent process which is closely linked together apoptosis and autophagy. It seems that NF-κB signaling, which is a potent antiapoptotic factor and inducer of inflammatory defence, could also have harmful consequences by inhibiting autophagocytosis.
3. Decline in Autophagy with Aging: Potential Role of NF-κB Signaling
3.1. Hallmarks of Inflammaging and Cellular Senescence
During the last decade, mounting evidence has revealed that there is a clear imbalance between adaptive and innate immunity in mammals during the aging process [126, 127]. Immunosenescence of adaptive immunity system enhances the activation of innate immunity responses which generates a proinflammatory phenotype, called inflammaging . The major characteristics of inflammaging are the increased expression of genes associated with inflammation in tissues [128, 129] and augmented levels of cytokines, for example, IL-6 and TNF-α, in serum [130, 131]. These observations agree with earlier studies indicating that the NF-κB system is activated with aging in many tissues [132–135]. Interestingly, inflammaging is also linked to a clear decline in autophagy [6–8, 136] as well as apoptosis [137–141]. Moreover, it seems that the aging process in vivo also involves the appearance of senescent cells which are resistant to apoptotic cell death [142–145]. Campisi et al.  have revealed that cellular senescence is linked to a proinflammatory phenotype called the senescence-associated secretory phenotype (SASP). Recent studies have indicated that the formation of this condition is stimulated by the activation of NF-κB signaling . Kang et al.  demonstrated that impairment of autophagy induces a premature senescence in normal human fibroblasts and on the other hand, replicatively senescent cells expressed reduced levels of autophagy proteins. However, autophagy can facilitate oncogene-induced senescence  and trigger autophagic cell death by increasing the expression of Noxa which is able to displace Bcl-2 family members from the Beclin 1 complex . Impaired autophagy supports the accumulation of waste materials into cells, called the “garbage-can hypothesis” by Brunk and Terman . Recent studies have indicated that the decline in autophagy and impaired housekeeping can stimulate NF-κB signaling and generate chronic inflammation via the activation of inflammasomes [4, 5, 152]. In particular, oxidative stress, which increases with aging, is a potent inducer of inflammasomes .
3.2. Age-Related Decline in the Expression of Autophagy Proteins
The mechanism of age-related decline in autophagy is still unclear. Genome-wide analysis of Lipinski et al.  indicated that autophagy could be transcriptionally downregulated during normal aging process in the human brain. Their study also revealed that aging could decrease the activity of type III PI3K (hVPS35), which is a crucial factor of Beclin 1 interactome during the nucleation phase of autophagy. Protein-protein interaction analysis revealed that RIP1 and PKCζ kinases and p62/sequestosome could be involved in the regulation of autophagy with aging. All of these three proteins are associated with NF-κB signaling and autophagy [154–156]. Hua et al.  observed a significant decrease in the protein levels of Beclin 1 and ATG5 whereas that of insoluble p62 was elevated, probably indicating its binding to protein aggregates in the hearts of old mice. Moreover, aging decreased the activity of AMPK whereas mTOR activity was increased, both of these changes could reduce autophagic activity. Wohlgemuth et al.  reported that the protein levels of ATG7, ATG9, and LAMP1 decreased but that of Beclin 1 was unaffected in old rat hearts. In general, these studies indicate that the expression of several autophagy proteins seems to be decreased during organismal aging as well as under cellular senescence in vitro conditions . However, the changes are small and tissue-specific and not repeatable in different studies which implies that many other factors in addition to the expression level can contribute to the decline in the autophagic process in conjunction with aging.
3.3. NF-κB Signaling Inhibits Autophagy via Beclin 1 Interactome during Aging Process
The regulation of the Beclin 1 interactome is a crucial control mechanism in the initiation of autophagy [13, 18]. As described earlier (Section 2.3.1), transcription factor NF-κB is an important transactivator of Beclin 1 itself as well as of several other binding partners, for example, Bcl-2, Bcl-xL, and NLRP4. Normally, Beclin 1 protein is complexed with Bcl-2/xL and autophagy is inhibited but the balance is dynamic and can be controlled by the availability of the different binding partners. Many reports have demonstrated that aging is linked to an increase in the expression of antiapoptotic Bcl-2 and Bcl-xL proteins, in particular in brain [159, 160]. Moreover, Satou et al.  observed that the immunoreactivity of Bcl-2 protein within neurons increased with the severity of Alzheimer's disease. It also seems that oxidative stress and accumulation of lipofuscin could enhance the expression of Bcl-2 in neurons with aging [159, 160]. Xu et al.  demonstrated that the intracerebroventricular injection of proinflammatory cytokines, TNF-α and IFNγ, markedly increased the expression of Bcl-2 in neurons of cortex and hippocampus. Interestingly, the response was age-related being clearly more prominent in the brains of old mice. This implies that inflammation, probably via the stimulation of NF-κB signaling, is a significant contributor to the decline of apoptosis and autophagy during aging.
Several studies have revealed that the expression of Bcl-2/xL proteins is clearly increased in senescent cells in vitro, simultaneously with the augmentation of apoptosis resistance [145, 163]. Wang  observed that serum deprivation reduced the level of Bcl-2 in young, proliferating human fibroblasts whereas in senescent cells, the expression level of Bcl-2 remained unchanged. This agrees with the observations that the capacity for autophagy is impaired in human senescent fibroblasts . Moreover, the overexpression of Bcl-2 reduces the lifespan of cultured human fibroblasts  as well as induces cellular senescence in human carcinoma cells . Lee et al.  demonstrated that the inhibition of JNK1 activity and subsequently the reduction in the level of Bcl-2 phosphorylation, the signal for autophagy (Section 2.3.1), induced cellular senescence both in human fibroblasts and carcinoma cells. This indicates that the autophagy via JNK/Bcl-2 phosphorylation is essential in the prevention of cellular senescence. These studies imply that Bcl-2/xL proteins have a crucial role with aging in the decline of apoptotic capacity as well as autophagy via the stabilization of Beclin 1 complexes. In view of the important function of NF-κB signaling in the generation of cellular senescence , it seems plausible that the overexpression of Bcl-2/xL has a major role in the appearance of the senescent phenotype.
A decline in autophagy with aging can also increase ROS production and stimulate the expression of inflammasome components via NF-κB signaling (Section 2.3.1). Interestingly, many of the inflammasome receptors can interact with Beclin 1, for example, NLRC4, NLRP3 and NLRP4, and inhibit autophagocytosis . The Beclin 1 interactome also contains HMGB1 proteins, enigmatic proteins which can regulate (i) genome function in nuclei, (ii) NF-κB transactivation, (iii) autophagy in cytoplasm, and (iv) inflammatory responses in extracellular space [167–170]. Tang et al.  demonstrated that HMGB1 could directly bind to Beclin 1 which displaced the inhibitory Bcl-2 protein from the complex and subsequently activated autophagy. HMGB1 is evolutionarily conserved and contains sequence homology with Beclin 1 which implies that it controls autophagocytosis. Inflammation and severe stress translocate the nuclear HMGB1 to the cytoplasm and extracellular space. ROS and oxidative stress oxidize the cysteine residues of HMGB1 which is required for the cytoplasmic translocation of HMGB1 and its binding to Beclin 1 and the subsequent stimulation of autophagy . On the other hand, the activation of NLRP3 inflammasomes triggers the secretion of HMGB1 protein into the extracellular space where it can bind several immune receptors and thus stimulate inflammatory responses . HMGB1 is an architectural factor in genome, for example, assisting in the binding of NF-κB complexes to DNA . There are age-related, tissue-specific changes in the expression of nuclear HMGB1 (previously called HMG-1), for example, the level of HMGB1 clearly decreases in brain (neurons), heart, lung, and thymus [173, 174]. In contrast, the overexpression of HMGB1 is one of the hallmarks of cancer . In this scenario, it seems that autophagy and inflammation are evolutionarily linked to each other to defend the host organism.
3.4. NF-κB Signaling Controls Autophagy via ROS Balance
In 1956, Harman  presented the free radical theory of aging which states that oxygenderived free radicals attack cellular constituents causing structural damage and impairing housekeeping functions. This theory has received substantial support since it was appreciated that the level of ROS-induced damage augments with aging. However, ROS are signaling molecules, for example, stimulating autophagy (Section 2.3.2) and it is known that the enhancement of autophagy increases the lifespan [136, 177]. Hekimi et al.  have proposed a gradual ROS response hypothesis, which maintains that low ROS levels activate signaling pathways which protect cells against different insults. The activation of autophagocytosis could represent that kind of protective response. However, with increases in the duration and input of stress, the accumulation of ROS could become detrimental and induce toxic responses. This theory could explain the apparently contradictory evidence that is, that a low level of oxidative stress can extend the lifespan in animal experiments . Recently, Morgan and Liu  reviewed the extensive crosstalk between ROS and NF-κB signaling. For instance, NF-κB signaling induces the expression of major antioxidants, for example, superoxide dismutases, thioredoxins, heme oxygenase, and glutathione peroxidase-1. On the other hand, NF-κB stimulates the expression of many ROS-producing enzymes, for example, NADPH oxidase-2, inducible NOS, and xanthine oxidase. ROS can also directly control the activity of NF-κB signaling in a cell type-specific manner . Moreover, Bauernfeind et al.  demonstrated that the NF-κB-provoked induction of NLRP3 expression, an inhibitory binding partner of Beclin 1 (Section 2.3.1), was highly dependent on the presence of ROS. In this way, ROS could inhibit the function of Beclin 1 initiation complex and thus repress autophagy. It seems that NF-κB signaling has a crucial role in the context-dependent regulation of autophagy. Currently, it is not known whether a low-grade inflammatory state with increased ROS levels could generate some feedback responses in the NF-κB signaling which might suppress autophagocytosis with aging.
3.5. Decline in Autophagy Activates IKKβ/NF-κB Signaling in Hypothalamus and Provokes Metabolic Syndrome
Metabolic syndrome is a major age-related disorder involving obesity, hypertension, diabetes, and cardiovascular diseases. Zhang et al.  demonstrated that overnutrition, a common cause of metabolic syndrome, activated IKKβ/NF-κB signaling in hypothalamic neurons and caused central insulin and leptin resistance. Further studies have revealed that excessive nutrition and systemic inflammation induced oxidative and endoplasmic stresses and activated NF-κB signaling in hypothalamus which subsequently triggered metabolic inflammation and provoked obesity and hypertension [182, 183]. Recently, Meng and Cai  demonstrated that the tissue-specific inhibition of autophagy in hypothalamus stimulated IKKβ/NF-κB signaling and induced inflammatory changes which were associated with the development of obesity and systemic insulin resistance. They also observed that the ablation of IKKβ abrogated the effects of deficient autophagy. These studies indicate that the decline in autophagy in hypothalamic neurons can lead to metabolic dysfunctions in many tissues and ultimately induce metabolic syndrome. Transgenic and knockout models have revealed complex, tissue-specific functions of NF-κB signaling . Moreover, aging responses are tissue-specific  and thus it needs to be clarified whether aging controls the tissue-specific crosstalk between autophagy and NF-κB system.
The NF-κB signaling system and autophagic degradation pathway are evolutionarily conserved, major cellular survival mechanisms. It is most likely that they have engaged in a close crosstalk with each other although its detailed characterization has remained elusive. There is emerging evidence indicating that the reciprocal regulation is highly dependent on the cellular context which emphasizes their fundamental role in host defence. Moreover, it seems that autophagy and apoptosis are controlled in cooperation with certain common regulatory proteins, for example, Bcl-2, Bcl-xL and BNIP3. It is also known that autophagy is an important regulator of inflammatory responses, in particular via the inflammasomes. Recent studies have revealed that the Beclin 1 interactome is a key player which controls autophagic initiation but it has also crucial effects on the function of apoptosis and inflammasomes. Interestingly, the NF-κB transcription factor directly regulates the transactivation of Beclin 1 and many other components of the Beclin 1 interactome. Moreover, NF-κB signaling controls the level of ROS and oxidative stress which are potent activators of autophagy. One puzzling aspect is that IKKα/β, close upstream kinases of NF-κB signaling, can in certain contexts stimulate autophagy without any activation of NF-κB signaling.
A decline in autophagic capacity is a hallmark of the aging process. Aging is also associated with increased apoptosis resistance and augmented inflammatory responses. Currently, it is not known whether the regulation mechanisms of autophagy, apoptosis, and inflammasomes are linked to each other but clearly they act in concert to aggravate the aging phenotype and expose tissues to the danger of age-related degenerative diseases. There are some indications that the Beclin 1 interactome and increased oxidative stress may be critically involved in the aging process. Several studies have revealed that NF-κB signaling is enhanced with aging which could explain the appearance of a low-grade inflammatory phenotype as well as the decline in autophagy and increased apoptosis resistance. Intriguingly, it is likely that the highly chronic nature of the aging process affects the regulation of autophagy by NF-κB signaling in a context dependent manner that is, impairing autophagy and inducing a proinflammatory aging phenotype.
|A20:||Ubiquitin-editing enzyme A20|
|ABIN-1:||A20-binding inhibitor of NF-κB1|
|ASC:||Apoptosis-associated speck-like protein containing a CARD|
|Akt:||Protein kinase B|
|AMPK:||AMP-activated protein kinase|
|BAD:||Bcl-2-associated death promoter protein|
|BAG3:||Bcl2-associated athanogene 3|
|BAX:||Bcl2-associated X protein|
|Bcl-xL:||B-cell lymphoma-extra large|
|BECN1:||Beclin 1 gene|
|Bfl-1:||Bcl2-related protein A1|
|BNIP3:||Bcl-2 adenovirus E1B 19 kDa-interacting protein 3|
|c-IAP2:||Apoptosis inhibitor 2|
|DAPK:||Death-associated protein kinase 1|
|DRAM1:||Damage-regulated autophagy modulator 1|
|E2F1:||E2F transcription factor 1|
|ECD:||Evolutionarily conserved domain|
|FKBP51:||FK506-binding protein 5|
|FoxO3:||Forkhead box O 3|
|Gadd45β:||Growth arrest- and DNA damage-inducible gene 45β|
|HDAC1:||Histone deacetylase 1|
|HMGB1:||High mobility group box 1|
|Hsp90:||Heat shock protein 90|
|HspB8:||Heat-shock 22-kD protein 8|
|hVPS34:||Vacuolar protein sorting 34 (mammalian homologue)|
|IκB:||Inhibitor of κB protein|
|IGF:||Insulin-like growth factor|
|IKKα/β:||Inhibitor of nuclear factor-κB kinase α/β|
|iNOS:||Inducible nitric oxide synthase|
|JNK1:||c-Jun NH(2)-terminal protein kinase 1|
|Keap1:||Kelch-like ECH-associated protein 1|
|LAMP1:||Lysosome-associated membrane protein 1|
|LC3:||Microtubule-associated protein 1A/1B-light chain 3|
|MEKK-1:||Mitogen-activated kinase kinase kinase 1|
|MKK7:||Mitogen-activated protein kinase kinase 7|
|mTOR:||Mammalian target of rapamycin|
|NACHT:||Nucleotide-binding protein domain|
|NADPH:||Nicotinamide adenine dinucleotide phosphate|
|NAF-1:||Nutrient-deprivation autophagy factor-1|
|NEMO:||NF-κB essential modulator|
|NIK:||NF-κB inducing kinase|
|NIX:||Bcl-2 adenovirus E1B 19 kDa-interacting protein 3-like|
|NLR:||Nucleotide-binding domain and leucine-rich repeat-containing family of proteins|
|PKCζ:||Protein kinase Cζ|
|PTEN:||Phosphatase and tensin homolog|
|Rel:||Proto-oncogene v-Rel homolog|
|RIP1:||Receptor-interacting protein 1|
|ROS:||Reactive oxygen species|
|SASP:||Senescence-associated secretory phenotype|
|Sin3a:||Sin3, yeast homolog A|
|SIRT1:||Silent information regulator 1|
|Sp1:||Transcription factor Sp1|
|TNF-α:||Tumor necrosis factor-α|
|TRAF6:||TNF receptor-associated factor 6|
|TWEAK:||TNF-related weak inducer of apoptosis|
|ULK1/2:||Unc-51-like kinase 1/2|
|XIAP:||Inhibitor of apoptosis, X-linked.|
This study was financially supported by grants from the Academy of Finland and the University of Eastern Finland, Kuopio, Finland. The authors thank Dr. Ewen MacDonald for checking the language of the manuscript.
- M. C. Haigis and B. A. Yankner, “The aging stress response,” Molecular Cell, vol. 40, no. 2, pp. 333–344, 2010.
- H. Koga, S. Kaushik, and A. M. Cuervo, “Protein homeostasis and aging: the importance of exquisite quality control,” Ageing Research Reviews, vol. 10, no. 2, pp. 205–215, 2011.
- T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000.
- O. Gross, C. J. Thomas, G. Guarda, and J. Tschopp, “The inflammasome: an integrated view,” Immunological Reviews, vol. 243, no. 1, pp. 136–151, 2011.
- A. Salminen, K. Kaarniranta, and A. Kauppinen, “Inflammaging: disturbed interplay between autophagy and inflammasomes,” Aging (Albany NY), vol. 4, no. 3, pp. 1–10, 2012.
- A. M. Cuervo, “Autophagy and aging: keeping that old broom working,” Trends in Genetics, vol. 24, no. 12, pp. 604–612, 2008.
- A. Salminen and K. Kaarniranta, “Regulation of the aging process by autophagy,” Trends in Molecular Medicine, vol. 15, no. 5, pp. 217–224, 2009.
- Y. S. Rajawat, Z. Hilioti, and I. Bossis, “Aging: central role for autophagy and the lysosomal degradative system,” Ageing Research Reviews, vol. 8, no. 3, pp. 199–213, 2009.
- D. J. Klionsky, “Autophagy: from phenomenology to molecular understanding in less than a decade,” Nature Reviews Molecular Cell Biology, vol. 8, no. 11, pp. 931–937, 2007.
- N. Mizushima, T. Yoshimori, and Y. Ohsumi, “The role of Atg proteins in autophagosome formation,” Annual Reviews in Cell and Developmental Biology, vol. 27, no. 1, pp. 107–132, 2011.
- I. Tanida, “Autophagosome formation and molecular mechanism of autophagy,” Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2201–2214, 2011.
- S. F. Funderburk, Q. J. Wang, and Z. Yue, “The Beclin 1-VPS34 complex—at the crossroads of autophagy and beyond,” Trends in Cell Biology, vol. 20, no. 6, pp. 355–362, 2010.
- C. He and B. Levine, “The Beclin 1 interactome,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 140–149, 2010.
- K. Matsunaga, E. Morita, T. Saitoh et al., “Autophagy requires endoplasmic reticulum targeting of the PI3-kinase complex via Atg14L,” Journal of Cell Biology, vol. 190, no. 4, pp. 511–521, 2010.
- S. Sinha and B. Levine, “The autophagy effector Beclin 1: a novel BH3-only protein,” Oncogene, vol. 27, no. 1, supplement, pp. S137–S148, 2008.
- Y. Wei, S. Pattingre, S. Sinha, M. Bassik, and B. Levine, “JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy,” Molecular Cell, vol. 30, no. 6, pp. 678–688, 2008.
- G. Bellot, R. Garcia-Medina, P. Gounon et al., “Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains,” Molecular and Cellular Biology, vol. 29, no. 10, pp. 2570–2581, 2009.
- R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, “The Beclin 1 network regulates autophagy and apoptosis,” Cell Death and Differentiation, vol. 18, no. 4, pp. 571–580, 2011.
- C. He and D. J. Klionsky, “Regulation mechanisms and signaling pathways of autophagy,” Annual Review of Genetics, vol. 43, pp. 67–93, 2009.
- G. Kroemer, G. Mariño, and B. Levine, “Autophagy and the Integrated Stress Response,” Molecular Cell, vol. 40, no. 2, pp. 280–293, 2010.
- B. Ravikumar, S. Sarkar, J. E. Davies et al., “Regulation of mammalian autophagy in physiology and pathophysiology,” Physiological Reviews, vol. 90, no. 4, pp. 1383–1435, 2010.
- B. Caballero and A. Coto-Montes, “An insight into the role of autophagy in cell responses in the aging and neurodegenerative brain,” Histology and Histopathology, vol. 27, no. 3, pp. 263–275, 2012.
- A. Oeckinghaus and S. Ghosh, “The NF-kappaB family of transcription factors and its regulation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 4, article a000034, 2009.
- G. Ghosh, V. Y. Wang, D. B. Huang, and A. Fusco, “NF-κB regulation: lessons from structures,” Immunological Reviews, vol. 246, no. 1, pp. 36–58, 2012.
- M. Hinz, S. C. Arslan, and C. Scheidereit, “It takes two to tango: IκBs, the multifunctional partners of NF-κB,” Immunological Reviews, vol. 246, no. 1, pp. 59–76, 2012.
- P. Tieri, A. Termanini, E. Bellavista, S. Salvioli, M. Capri, and C. Franceschi, “Charting the NF-κB pathway interactome map,” PLoS ONE, vol. 7, no. 3, Article ID e32678, 2012.
- N. D. Perkins, “Integrating cell-signalling pathways with NF-κB and IKK function,” Nature Reviews Molecular Cell Biology, vol. 8, no. 1, pp. 49–62, 2007.
- M. S. Hayden and S. Ghosh, “Shared Principles in NF-κB Signaling,” Cell, vol. 132, no. 3, pp. 344–362, 2008.
- A. Oeckinghaus, M. S. Hayden, and S. Ghosh, “Crosstalk in NF-κB signaling pathways,” Nature Immunology, vol. 12, no. 8, pp. 695–708, 2011.
- A. Chariot, “The NF-κB-independent functions of IKK subunits in immunity and cancer,” Trends in Cell Biology, vol. 19, no. 8, pp. 404–413, 2009.
- B. Huang, X. D. Yang, A. Lamb, and L. F. Chen, “Posttranslational modifications of NF-κB: another layer of regulation for NF-κB signaling pathway,” Cellular Signalling, vol. 22, no. 9, pp. 1282–1290, 2010.
- S. T. Smale, “Hierarchies of NF-κB target-gene regulation,” Nature Immunology, vol. 12, no. 8, pp. 689–694, 2011.
- N. ] Sen, B. D. Paul, M. M. Gadalla et al., “Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions,” Molecular Cell, vol. 45, no. 1, pp. 13–24, 2012.
- T. Lawrence and C. Fong, “The resolution of inflammation: anti-inflammatory roles for NF-κB,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 4, pp. 519–523, 2010.
- Q. Meng and D. Cai, “Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IκB kinase β (IKKβ)/NF-κB pathway,” The Journal of Biological Chemistry, vol. 286, no. 37, pp. 32324–32332, 2011.
- B. Levine, N. Mizushima, and H. W. Virgin, “Autophagy in immunity and inflammation,” Nature, vol. 469, no. 7330, pp. 323–335, 2011.
- A. Salminen, J. M. T. Hyttinen, and K. Kaarniranta, “AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan,” Journal of Molecular Medicine, vol. 89, no. 7, pp. 667–676, 2011.
- F. Yeung, J. E. Hoberg, C. S. Ramsey et al., “Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase,” EMBO Journal, vol. 23, no. 12, pp. 2369–2380, 2004.
- I. H. Lee , L. Cao, R. Mostoslavsky et al., “A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 9, pp. 3374–3379, 2008.
- A. Trocoli and M. Djavaheri-Mergny, “The complex interplay between autophagy and NF-κB signaling pathways in cancer cells,” American Journal of Cancer Research, vol. 1, no. 5, pp. 629–649, 2011.
- A. Criollo, L. Senovilla, H. Authier et al., “The IKK complex contributes to the induction of autophagy,” EMBO Journal, vol. 29, no. 3, pp. 619–631, 2010.
- W. C. Comb, P. Cogswell, R. Sitcheran, and A. S. Baldwin, “IKK-dependent, NF-κB-independent control of autophagic gene expression,” Oncogene, vol. 30, no. 14, pp. 1727–1732, 2011.
- W. C. Comb, J. E. Hutti, P. Cogswell, L. C. Cantley, and A. S. Baldwin, “p85α SH2 domain phosphorylation by IKK promotes feedback inhibition of PI3K and Akt in response to cellular starvation,” Molecular Cell, vol. 45, no. 6, pp. 719–730, 2012.
- M. Broemer, D. Krappmann, and C. Scheidereit, “Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation,” Oncogene, vol. 23, no. 31, pp. 5378–5386, 2004.
- M. Hinz, M. Broemer, S. Ç. Arslan et al., “Signal responsiveness of IκB kinases is determined by Cdc37-assisted transient interaction with Hsp90,” The Journal of Biological Chemistry, vol. 282, no. 44, pp. 32311–32319, 2007.
- A. Salminen, T. Paimela, T. Suuronen, and K. Kaarniranta, “Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90,” Immunology Letters, vol. 117, no. 1, pp. 9–15, 2008.
- J. F. Pittet, H. Lee, M. Pespeni, A. O'Mahony, J. Roux, and W. J. Welch, “Stress-induced inhibition of the NF-κB signaling pathway results from the insolubilization of the IκB kinase complex following its dissociation from heat shock protein 90,” Journal of Immunology, vol. 174, no. 1, pp. 384–394, 2005.
- G. Qing, P. Yan, and G. Xiao, “Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IκB kinase (IKK),” Cell Research, vol. 16, no. 11, pp. 895–901, 2006.
- G. Qing, P. Yan, Z. Qu, H. Liu, and G. Xiao, “Hsp90 regulates processing of NF-kB2 p100 involving protection of NF-kB-inducing kinase (NIK) from autophagy-mediated degradation,” Cell Research, vol. 17, no. 6, pp. 520–530, 2007.
- M. Niida, M. Tanaka, and T. Kamitani, “Downregulation of active IKKβ by Ro52-mediated autophagy,” Molecular Immunology, vol. 47, no. 14, pp. 2378–2387, 2010.
- J. E. Kim, D. J. You, C. Lee, C. Ahn, J. Y. Seong, and J. I. Hwang, “Suppression of NF-κB signaling by KEAP1 regulation of IKKβ activity through autophagic degradation and inhibition of phosphorylation,” Cellular Signalling, vol. 22, no. 11, pp. 1645–1654, 2010.
- M. Nivon, E. Richet, P. Codogno, A. P. Arrigo, and C. Kretz-Remy, “Autophagy activation by NFκB is essential for cell survival after heat shock,” Autophagy, vol. 5, no. 6, pp. 766–783, 2009.
- M. Nivon, M. Abou-Samra, E. Richet, B. Guyot, A. P. Arrigo, and C. Kretz-Remy, “NF-κB regulates protein quality control after heat stress through modulation of the BAG3-HspB8,” Journal of Cell Science, vol. 125, no. 1, pp. 1–11, 2012.
- S. Carra, S. J. Seguin, and J. Landry, “HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy,” Autophagy, vol. 4, no. 2, pp. 237–239, 2008.
- C. Kretz-Remy, B. Munseh, and A. P. Arrigo, “NFκB-dependent transcriptional activation during heat shock recovery: thermolability of the NF-κB·IκB complex,” The Journal of Biological Chemistry, vol. 276, no. 47, pp. 43723–43733, 2001.
- T. Copetti, C. Bertoli, E. Dalla, F. Demarchi, and C. Schneider, “p65/RelA modulates BECN1 transcription and autophagy,” Molecular and Cellular Biology, vol. 29, no. 10, pp. 2594–2608, 2009.
- S. Bhatnagar, A. Mittal, S. K. Gupta, and A. Kumar, “TWEAK causes myotubes atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases,” Journal of Cellular Physiology, vol. 227, no. 3, pp. 1042–1051, 2012.
- C. Dogra, H. Changotra, N. Wedhas, X. Qin, J. E. Wergedal, and A. Kumar, “TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine,” FASEB Journal, vol. 21, no. 8, pp. 1857–1869, 2007.
- A. Kumar, S. Bhatnagar, and P. K. Paul, “TWEAK and TRAF6 regulate skeletal muscle atrophy,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 15, no. 2, pp. 233–239, 2012.
- C. S. Shi and J. H. Kehrl, “TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced Autophagy,” Science Signaling, vol. 3, no. 123, article ra42, 2010.
- Q. Jiang, Y. Wang, T. Li et al., “Heat shock protein 90-mediated inactivation of nuclear factor-kB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells,” Molecular Biology of the Cell, vol. 22, no. 8, pp. 1167–1180, 2011.
- S. Romano, A. D'Angelillo, R. Pacelli et al., “Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells,” Cell Death and Differentiation, vol. 17, no. 1, pp. 145–157, 2010.
- Y. Tsuboi, M. Kurimoto, S. Nagai et al., “Induction of autophagic cell death and radiosensitization by the pharmacological inhibition of nuclear factor-kappa B activation in human glioma cell lines: laboratory investigation,” Journal of Neurosurgery, vol. 110, no. 3, pp. 594–604, 2009.
- Y. Zhang, Y. Wu, D. Wu, S. I. Tashiro, S. Onodera, and T. Ikejima, “NF-κb facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway,” Archives of Biochemistry and Biophysics, vol. 489, no. 1-2, pp. 25–33, 2009.
- J. Hwang, H. J. Lee, W. H. Lee, and K. Suk, “NF-B as a common signaling pathway in ganglioside-induced autophagic cell death and activation of astrocytes,” Journal of Neuroimmunology, vol. 226, no. 1-2, pp. 66–72, 2010.
- G. Kroemer and B. Levine, “Autophagic cell death: the story of a misnomer,” Nature Reviews Molecular Cell Biology, vol. 9, no. 12, pp. 1004–1010, 2008.
- M. Djavaheri-Mergny, M. Amelotti, J. Mathieu et al., “NF-κB activation represses tumor necrosis factor-α-induced autophagy,” The Journal of Biological Chemistry, vol. 281, no. 41, pp. 30373–30382, 2006.
- J. Huang, G. Y. Lam, and J. H. Brumell, “Autophagy signaling through reactive oxygen species,” Antioxidants and Redox Signaling, vol. 14, no. 11, pp. 2215–2231, 2011.
- D. F. Lee, H. P. Kuo, C. T. Chen et al., “IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway,” Cell, vol. 130, no. 3, pp. 440–455, 2007.
- H. C. Dan and A. S. Baldwin, “Differential involvement of IκB kinases α and β in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt,” Journal of Immunology, vol. 180, no. 11, pp. 7582–7589, 2008.
- S. Kim, C. Domon-Dell, J. Kang, D. H. Chung, J. N. Freund, and B. M. Evers, “Down-regulation of the tumor Ssuppressor PTEN by the tumor necrosis factor-α/nuclear factor-κB (NF-κB)-inducing kinase/NF-κB pathway is linked to a default IκB-α Autoregulatory Loop,” The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4285–4291, 2004.
- K. M. Vasudevan, S. Gurumurthy, and V. M. Rangnekar, “Suppression of PTEN Expression by NF-κB Prevents Apoptosis,” Molecular and Cellular Biology, vol. 24, no. 3, pp. 1007–1021, 2004.
- A. Salminen and K. Kaarniranta, “Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-κB signaling,” Cellular Signalling, vol. 22, no. 4, pp. 573–577, 2010.
- S. Schlottmann, F. Buback, B. Stahl et al., “Prolonged classical NF-κB activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammation,” Mediators of Inflammation, vol. 2008, Article ID 725854, 2008.
- F. Zhou, Y. Yang, and D. Xing, “Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis,” FEBS Journal, vol. 278, no. 3, pp. 403–413, 2011.
- E. Zalckvar, H. Berissi, L. Mizrachy et al., “DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy,” EMBO Reports, vol. 10, no. 3, pp. 285–292, 2009.
- Y. K. Han, T. K. Ha, Y. G. Kim, and G. M. Lee, “Bcl-xL overexpression delays the onset of autophagy and apoptosis in hyperosmotic recombinant Chinese hamster ovary cell cultures,” Journal of Biotechnology, vol. 156, no. 1, pp. 52–55, 2011.
- X. D. Zhang, Y. Wang, J. C. Wu et al., “Down-regulation of Bcl-2 enhances autophagy activation and cell death induced by mitochondrial dysfunction in rat striatum,” Journal of Neuroscience Research, vol. 87, no. 16, pp. 3600–3610, 2009.
- M. Tamatani, Y. H. Che, H. Matsuzaki et al., “Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons,” The Journal of Biological Chemistry, vol. 274, no. 13, pp. 8531–8538, 1999.
- C. Chen, L. C. Edelstein, and C. Gélinas, “The Rel/NF-κb family directly activates expression of the apoptosis inhibitor BCl-x(L),” Molecular and Cellular Biology, vol. 20, no. 8, pp. 2687–2695, 2000.
- J. N. Glasgow, T. Wood, and J. R. Perez-Polo, “Identification and characterization of nuclear factor κB binding sites in the murine bcl-x promoter,” Journal of Neurochemistry, vol. 75, no. 4, pp. 1377–1389, 2000.
- S. D. Catz and J. L. Johnson, “Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer,” Oncogene, vol. 20, no. 50, pp. 7342–7351, 2001.
- P. Viatour, M. Bentires-Alj, A. Chariot et al., “NF-κB2/p100 induces Bcl-2 expression,” Leukemia, vol. 17, no. 7, pp. 1349–1356, 2003.
- L. C. Edelstein, L. Lagos, M. Simmons, H. Tirumalai, and C. Gélinas, “NF-κB-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1,” Molecular and Cellular Biology, vol. 23, no. 8, pp. 2749–2761, 2003.
- M. Kathania, C. I. Raje, M. Raje, R. K. Dutta, and S. Majumdar, “Bfl-1/A1 acts as a negative regulator of autophagy in mycobacteria infected macrophages,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 4, pp. 573–585, 2011.
- N. C. Chang, M. Nguyen, M. Germain, and G. C. Shore, “Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1,” EMBO Journal, vol. 29, no. 3, pp. 606–618, 2010.
- L. A. Kirshenbaum, “Bcl-2 intersects the NFκB signalling pathway and suppresses apoptosis in ventricular myocytes,” Clinical and Investigative Medicine, vol. 23, no. 5, pp. 322–330, 2000.
- K. M. Regula, K. Ens, and L. A. Kirshenbaum, “IKKβ is required for Bcl-2-mediated NF-κB activation in ventricular myocytes,” The Journal of Biological Chemistry, vol. 277, no. 41, pp. 38676–38682, 2002.
- L. Vereecke, R. Beyaert, and G. van Loo, “The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology,” Trends in Immunology, vol. 30, no. 8, pp. 383–391, 2009.
- L. Amir-Zilberstein and R. Dikstein, “Interplay between E-box and NF-κB in regulation of A20 gene by DRB sensitivity-inducing factor (DSIF),” The Journal of Biological Chemistry, vol. 283, no. 3, pp. 1317–1323, 2008.
- L. Verstrepen, K. Verhelst, G. van Loo, I. Carpentier, S. C. Ley, and R. Beyaert, “Expression, biological activities and mechanisms of action of A20 (TNFAIP3),” Biochemical Pharmacology, vol. 80, no. 12, pp. 2009–2020, 2010.
- N. Shembade and E. W. Harhaj, “Regulation of NF-κB signaling by the A20 deubiquitinase,” Cellular & Molecular Immunology, vol. 9, no. 2, pp. 123–139, 2012.
- B. Skaug, J. Chen, F. Du, J. He, A. Ma, and Z. J. Chen, “Direct, noncatalytical mechanism of IKK inhibition by A20,” Molecular Cell, vol. 44, no. 4, pp. 559–571, 2011.
- C. Mauro, F. Pacifico, A. Lavorgna et al., “ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB,” The Journal of Biological Chemistry, vol. 281, no. 27, pp. 18482–18488, 2006.
- N. Jounai, K. Kobiyama, M. Shiina, K. Ogata, K. J. Ishii, and F. Takeshita, “NLRP4 negatively regulates autophagic processes through an association with Beclin1,” Journal of Immunology, vol. 186, no. 3, pp. 1646–1655, 2011.
- K. Schroder and J. Tschopp, “The Inflammasomes,” Cell, vol. 140, no. 6, pp. 821–832, 2010.
- F. G. Bauernfeind, G. Horvath, A. Stutz et al., “Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression,” Journal of Immunology, vol. 183, no. 2, pp. 787–791, 2009.
- C. S. Shi, K. Shenderov, N. N. Huang et al., “Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction,” Nature Immunology, vol. 13, no. 3, pp. 255–263, 2012.
- J. M. Bruey, N. Bruey-Sedano, F. Luciano et al., “Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1,” Cell, vol. 129, no. 1, pp. 45–56, 2007.
- B. Faustin, Y. Chen, D. Zhai et al., “Mechanism of Bcl-2 and Bcl-XL inhibition of NLRP1 inflammasome: loop domain-dependent suppression of ATP binding and oligomerization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 3935–3940, 2009.
- R. Scherz-Shouval and Z. Elazar, “Regulation of autophagy by ROS: physiology and pathology,” Trends in Biochemical Sciences, vol. 36, no. 1, pp. 30–38, 2011.
- J. Lee, S. Giordano, and J. Zhang, “Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling,” Biochemical Journal, vol. 441, no. 2, pp. 523–540, 2012.
- A. Pautz, J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert, “Regulation of the expression of inducible nitric oxide synthase,” Nitric Oxide, vol. 23, no. 1, pp. 75–93, 2010.
- S. Sarkar, V. I. Korolchuk, M. Renna et al., “Complex inhibitory effects of nitric oxide on autophagy,” Molecular Cell, vol. 43, no. 1, pp. 19–32, 2011.
- S. Alers, A. S. Löffler, S. Wesselborg, and B. Stork, “Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks,” Molecular and Cellular Biology, vol. 32, no. 1, pp. 2–11, 2012.
- N. M. Mazure and J. Pouysségur, “Hypoxia-induced autophagy: cell death or cell survival?” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 177–180, 2010.
- G. Chinnadurai, S. Vijayalingam, and S. B. Gibson, “BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions,” Oncogene, vol. 27, no. 1, supplement, pp. S114–S127, 2008.
- X. Feng, X. Liu, W. Zhang, and W. Xiao, “p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death,” EMBO Journal, vol. 30, no. 16, pp. 3397–3415, 2011.
- H. Gang, R. Dhingra, Y. Wang, W. Mughal, J. W. Gordon, and L. A. Kirshenbaum, “Epigenetic regulation of E2F-1-dependent Bnip3 transcription and cell death by nuclear factor-κB and histone deacetylase-1,” Pediatric Cardiology, vol. 32, no. 3, pp. 263–266, 2011.
- D. Baetz, K. M. Regula, K. Ens et al., “Nuclear factor-κB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes,” Circulation, vol. 112, no. 24, pp. 3777–3785, 2005.
- J. Shaw, N. Yurkova, T. Zhang et al., “Antagonism of E2F-1 regulated Bnip3 transcription by NF-κB is essential for basal cell survival,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 52, pp. 20734–20739, 2008.
- R. Singh and A. M. Cuervo, “Autophagy in the cellular energetic balance,” Cell Metabolism, vol. 13, no. 5, pp. 495–504, 2011.
- S. Pattingre, C. Bauvy, S. Carpentier, T. Levade, B. Levine, and P. Codogno, “Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy,” The Journal of Biological Chemistry, vol. 284, no. 5, pp. 2719–2728, 2009.
- S. Papa, C. Bubici, F. Zazzeroni et al., “The NF-κB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease,” Cell Death and Differentiation, vol. 13, no. 5, pp. 712–729, 2006.
- C. Bubici, S. Papa, C. G. Pham, F. Zazzeroni, and G. Franzoso, “The NF-κB-mediated control of ROS and JNK signaling,” Histology and Histopathology, vol. 21, no. 1–3, pp. 69–80, 2006.
- H. Nakano, A. Nakajima, S. Sakon-Komazawa, J. H. Piao, X. Xue, and K. Okumura, “Reactive oxygen species mediate crosstalk between NF-κB and JNK,” Cell Death and Differentiation, vol. 13, no. 5, pp. 730–737, 2006.
- J. Liu and A. Lin, “Wiring the cell signaling circuitry by the NF-κB and JNK1 crosstalk and its applications in human diseases,” Oncogene, vol. 26, no. 22, pp. 3267–3278, 2007.
- M. M. Lipinski, B. Zheng, T. Lu et al., “Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14164–14169, 2010.
- M. J. Morgan and Z. G. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, no. 1, pp. 103–115, 2011.
- M. C. Maiuri, E. Tasdemir, A. Criollo et al., “Control of autophagy by oncogenes and tumor suppressor genes,” Cell Death and Differentiation, vol. 16, no. 1, pp. 87–93, 2009.
- E. L. Eskelinen, “The dual role of autophagy in cancer,” Current Opinion in Pharmacology, vol. 11, no. 4, pp. 294–300, 2011.
- G. M. Balaburski, R. D. Hontz, and M. E. Murphy, “P53 and ARF: unexpected players in autophagy,” Trends in Cell Biology, vol. 20, no. 6, pp. 363–369, 2010.
- J. A. DiDonato, F. Mercurio, and M. Karin, “NF-κB and the link between inflammation and cancer,” Immunological Reviews, vol. 246, no. 1, pp. 379–400, 2012.
- P. Ak and A. J. Levine, “p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism,” FASEB Journal, vol. 24, no. 10, pp. 3643–3652, 2010.
- K. M. Ryan, “P53 and autophagy in cancer: guardian of the genome meets guardian of the proteome,” European Journal of Cancer, vol. 47, no. 1, pp. 44–50, 2011.
- C. Franceschi, S. Valensin, M. Bonafè et al., “The network and the remodeling theories of aging: historical background and new perspectives,” Experimental Gerontology, vol. 35, no. 6-7, pp. 879–896, 2000.
- A. Larbi, C. Franceschi, D. Mazzatti, R. Solana, A. Wikby, and G. Pawelec, “Aging of the immune system as a prognostic factor for human longevity,” Physiology, vol. 23, no. 2, pp. 64–74, 2008.
- J. P. de Magalhães, J. Curado, and G. M. Church, “Meta-analysis of age-related gene expression profiles identifies common signatures of aging,” Bioinformatics, vol. 25, no. 7, pp. 875–881, 2009.
- W. R. Swindell, “Genes and gene expression modules associated with caloric restriction and aging in the laboratory mouse,” BMC Genomics, vol. 10, article 585, 2009.
- K. S. Krabbe, M. Pedersen, and H. Bruunsgaard, “Inflammatory mediators in the elderly,” Experimental Gerontology, vol. 39, no. 5, pp. 687–699, 2004.
- T. Singh and A. B. Newman, “Inflammatory markers in population studies of aging,” Ageing Research Reviews, vol. 10, no. 3, pp. 319–329, 2011.
- M. Helenius, M. Hänninen, S. K. Lehtinen, and A. Salminen, “Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κB,” Biochemical Journal, vol. 318, no. 2, pp. 603–608, 1996.
- N. F. L. Spencer, M. E. Poynter, S. Y. Im, and R. A. Daynes, “Constitutive activation of NF-κB in an animal model of aging,” International Immunology, vol. 9, no. 10, pp. 1581–1588, 1997.
- M. Helenius, S. Kyrylenko, P. Vehviläinen, and A. Salminen, “Characterization of aging-associated up-regulation of constitutive nuclear factor-κB binding activity,” Antioxidants and Redox Signaling, vol. 3, no. 1, pp. 147–156, 2001.
- A. S. Adler, S. Sinha, T. L. A. Kawahara, J. Y. Zhang, E. Segal, and H. Y. Chang, “Motif module map reveals enforcement of aging by continual NF-κB activity,” Genes and Development, vol. 21, no. 24, pp. 3244–3257, 2007.
- D. C. Rubinsztein, G. Marino, and G. Kroemer, “Autophagy and aging,” Cell, vol. 146, no. 5, pp. 682–695, 2011.
- E. Wang, “Regulation of apoptosis resistance and ontogeny of age-dependent diseases,” Experimental Gerontology, vol. 32, no. 4-5, pp. 471–484, 1997.
- N. Bye, M. Zieba, N. G. Wreford, and N. R. Nichols, “Resistance of the dentate gyrus to induced apoptosis during ageing is associated with increases in transforming growth factor-β1 messenger RNA,” Neuroscience, vol. 105, no. 4, pp. 853–862, 2001.
- Y. Zhang and B. Herman, “Ageing and apoptosis,” Mechanisms of Ageing and Development, vol. 123, no. 4, pp. 245–260, 2002.
- N. Kavathia, A. Jain, J. Walston, B. A. Beamer, and N. S. Fedarko, “Serum markers of apoptosis decrease with age and cancer stage,” Aging, vol. 1, no. 7, pp. 652–663, 2009.
- A. Salminen, J. Ojala, and K. Kaarniranta, “Apoptosis and aging: increased resistance to apoptosis enhances the aging process,” Cellular and Molecular Life Sciences, vol. 68, no. 6, pp. 1021–1031, 2011.
- D. Monti, S. Salvioli, M. Capri et al., “Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians,” Mechanisms of Ageing and Development, vol. 121, no. 1–3, pp. 239–250, 2001.
- J. Krishnamurthy, C. Torrice, M. R. Ramsey et al., “Ink4a/Arf expression is a biomarker of aging,” Journal of Clinical Investigation, vol. 114, no. 9, pp. 1299–1307, 2004.
- J. C. Jeyapalan, M. Ferreira, J. M. Sedivy, and U. Herbig, “Accumulation of senescent cells in mitotic tissue of aging primates,” Mechanisms of Ageing and Development, vol. 128, no. 1, pp. 36–44, 2007.
- P. J. Rochette and D. E. Brash, “Progressive apoptosis resistance prior to senescence and control by the anti-apoptotic protein BCL-xL,” Mechanisms of Ageing and Development, vol. 129, no. 4, pp. 207–214, 2008.
- J. Campisi, J. K. Andersen, P. Kapahi, and S. Melov, “Cellular senescence: a link between cancer and age-related degenerative disease?” Seminars in Cancer Biology, vol. 21, no. 6, pp. 354–359, 2011.
- A. Salminen, A. Kauppinen, and K. Kaarniranta, “Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP),” Cellular Signaling, vol. 24, no. 4, pp. 835–845, 2012.
- H. T. Kang, K. B. Lee, S. Y. Kim, H. R. Choi, and S. C. Park, “Autophagy impairment induces premature senescence in primary human fibroblasts,” PLoS ONE, vol. 6, no. 8, article e23367, 2011.
- A. R. J. Young, M. Narita, M. Ferreira et al., “Autophagy mediates the mitotic senescence transition,” Genes and Development, vol. 23, no. 7, pp. 798–803, 2009.
- M. Elgendy, C. Sheridan, G. Brumatti, and S. J. Martin, “Oncogenic ras-induced expression of noxa and beclin-1 promotes autophagic cell death and limits clonogenic survival,” Molecular Cell, vol. 42, no. 1, pp. 23–35, 2011.
- U. T. Brunk and A. Terman, “The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis,” European Journal of Biochemistry, vol. 269, no. 8, pp. 1996–2002, 2002.
- T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell, “Inflammasomes in health and disease,” Nature, vol. 481, no. 7381, pp. 278–286, 2012.
- J. Tschopp and K. Schroder, “NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?” Nature Reviews Immunology, vol. 10, no. 3, pp. 210–215, 2010.
- J. Moscat, P. Rennert, and M. T. Diaz-Meco, “PKCζ at the crossroad of NF-κB and Jak1/Stat6 signaling pathways,” Cell Death and Differentiation, vol. 13, no. 5, pp. 702–711, 2006.
- N. Festjens, T. Vanden Berghe, S. Cornelis, and P. Vandenabeele, “RIP1, a kinase on the crossroads of a cell's decision to live or die,” Cell Death and Differentiation, vol. 14, no. 3, pp. 400–410, 2007.
- T. Johansen and T. Lamark, “Selective autophagy mediated by autophagic adapter proteins,” Autophagy, vol. 7, no. 3, pp. 279–296, 2011.
- Y. Hua, Y. Zhang, A. F. Ceylan-Isik, L. E. Wold, J. M. Nunn, and J. Ren, “Chronic akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy,” Basic Research in Cardiology, vol. 106, no. 6, pp. 1173–1191, 2011.
- S. E. Wohlgemuth, D. Julian, D. E. Akin et al., “Autophagy in the heart and liver during normal aging and calorie restriction,” Rejuvenation Research, vol. 10, no. 3, pp. 281–292, 2007.
- A. Migheli, P. Cavalla, R. Piva, M. T. Giordana, and D. Schiffer, “Bcl-2 protein expression in aged brain and neurodegenerative diseases,” NeuroReport, vol. 5, no. 15, pp. 1906–1908, 1994.
- J. A. Kaufmann, P. C. Bickford, and G. Taglialatela, “Oxidative-stress-dependent up-regulation of Bcl-2 expression in the central nervous system of aged Fisher-344 rats,” Journal of Neurochemistry, vol. 76, no. 4, pp. 1099–1108, 2001.
- T. Satou, B. J. Cummings, and C. W. Cotman, “Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity,” Brain Research, vol. 697, no. 1-2, pp. 35–43, 1995.
- Y. Z. Xu, X. H. Deng, and M. Bentivoglio, “Differential response of apoptosis-regulatory Bcl-2 and Bax proteins to an inflammatory challenge in the cerebral cortex and hippocampus of aging mice,” Brain Research Bulletin, vol. 74, no. 5, pp. 329–335, 2007.
- E. Wang, “Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved,” Cancer Research, vol. 55, no. 11, pp. 2284–2292, 1995.
- T. Kumazaki, M. Sasaki, M. Nishiyama et al., “Life span shortening of normal fibroblasts by overexpression of BCL-2: a result of potent increase in cell death,” Experimental Cell Research, vol. 285, no. 2, pp. 299–308, 2003.
- E. Crescenzi, G. Palumbo, and H. J. M. Brady, “Bcl-2 activates a programme of premature senescence in human carcinoma cells,” Biochemical Journal, vol. 375, no. 2, pp. 263–274, 2003.
- J. J. Lee, J. H. Lee, Y. G. Ko, S. I. Hong, and J. S. Lee, “Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species,” Oncogene, vol. 29, no. 4, pp. 561–575, 2010.
- A. Agresti, R. Lupo, M. E. Bianchi, and S. Müller, “HMGB1 interacts differentially with members of the Rel family of transcription factors,” Biochemical and Biophysical Research Communications, vol. 302, no. 2, pp. 421–426, 2003.
- R. Kang, K. M. Livesey, H. J. Zeh, M. T. Lotze, and D. Tang, “HMGB1: a novel Beclin 1-binding protein active in autophagy,” Autophagy, vol. 6, no. 8, pp. 1209–1211, 2010.
- M. Štros, “HMGB proteins: interactions with DNA and chromatin,” Biochimica et Biophysica Acta, vol. 1799, no. 1-2, pp. 101–113, 2010.
- D. Tang, R. Kang, H. J. Zeh, and M. T. Lotze, “High-mobility group box 1, oxidative stress, and disease,” Antioxidants and Redox Signaling, vol. 14, no. 7, pp. 1315–1335, 2011.
- D. Tang, R. Kang, K. M. Livesey et al., “Endogenous HMGB1 regulates autophagy,” Journal of Cell Biology, vol. 190, no. 5, pp. 881–892, 2010.
- L. van de Walle, T. D. Kanneganti, and M. Lamkanfi, “HMGB1 release by inflammasomes,” Virulence, vol. 2, no. 2, pp. 162–165, 2011.
- S. Prasad and M. K. Thakur, “Distribution of high mobility group proteins in different tissues of rats during aging,” Biochemistry International, vol. 20, no. 4, pp. 687–695, 1990.
- Y. Enokido, A. Yoshitake, H. Ito, and H. Okazawa, “Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain,” Biochemical and Biophysical Research Communications, vol. 376, no. 1, pp. 128–133, 2008.
- D. Tang, R. Kang, H. J. Zeh, and M. T. Lotze, “High-mobility group box 1 and cancer,” Biochimica et Biophysica Acta, vol. 1799, no. 1-2, pp. 131–140, 2010.
- D. Harman, “Aging: a theory based on free radical and radiation chemistry,” Journal of gerontology, vol. 11, no. 3, pp. 298–300, 1956.
- G. Petrovski and D. K. Das, “Does autophagy take a front seat in lifespan extension?” Journal of Cellular and Molecular Medicine, vol. 14, no. 11, pp. 2543–2551, 2010.
- S. Hekimi, J. Lapointe, and Y. Wen, “Taking a “good” look at free radicals in the aging process,” Trends in Cell Biology, vol. 21, no. 10, pp. 569–576, 2011.
- M. Ristow and S. Schmeisser, “Extending life span by increasing oxidative stress,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 327–336, 2011.
- F. Bauernfeind, E. Bartok, A. Rieger, L. Franchi, G. Núñez, and V. Hornung, “Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome,” Journal of Immunology, vol. 187, no. 2, pp. 613–617, 2011.
- X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai, “Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity,” Cell, vol. 135, no. 1, pp. 61–73, 2008.
- S. Purkayastha, H. Zhang, G. Zhang, Z. Ahmed, Y. Wang, and D. Cai, “Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 7, pp. 2939–2944, 2011.
- D. Cai and T. Liu, “Inflammatory cause of metabolic syndrome via brain stress and NF-κB,” Aging (Albany NY), vol. 4, no. 2, pp. 98–115, 2012.
- S. Gerondakis, R. Grumont, R. Gugasyan et al., “Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models,” Oncogene, vol. 25, no. 51, pp. 6781–6799, 2006.
- W. R. Swindell, A. Johnston, L. Sun et al., “Meta-profiles of gene expression during aging: limited similarities between mouse and human and an unexpectedly decreased inflammatory signature,” PLoS ONE, vol. 7, 3, article e33204, 2012.